MI is also associated with the release of vascular endothelial growth factor receptor 2 (VEGFR2), IL-6, and versican from bone marrow ECs, inducing bone marrow endothelial dysfunction and favoring local inflammatory cytokine release [45]. The gene discussed is KDR; the disease is myocardial infarction.